ArticleNature communications2024

CRISPR/Cas9 model of prostate cancer identifies Kmt2c deficiency as a metastatic driver by Odam/Cabs1 gene cluster expression.

Huiqiang Cai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.